First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
An Open, Randomized, Multicentre, Phase II Pilot Study
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel in the Treatment of Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2